Select Page

ELZA’s role in corneal disease

Members of the ELZA Institute have contributed significantly to the improvement of currently used technologies that reshape the human cornea.

One of our primary research foci is on corneal diseases that can lead to irregular astigmatism that cannot be corrected by spectacles. These diseases can be very debilitating, as they can massively reduce people’s visual acuity and in some cases, render them effectively blind. A typical cause of this amount of irregular astigmatism is keratoconus (and other corneal ectasias like Terrien’s or Pellucid Marginal Degeneration) but scarring due to corneal infection or injury are also common causes. It could happen to anyone. 

ELZA’s surgeons and researchers are heavily focused in progressing the field in terms of not only treating ectasias with cross-linking, but also using the excimer laser, where possible, to improve vision post-cross-linking vision. 

With our research laboratories at both the University of Zurich and the University of Southern California in Los Angeles, we are deeply involved in research on this topic and our members give numerous international lectures every year across Europe, Asia, Africa and America.

ELZA at the CXL Experts Meeting 2018 in Zurich

The Cross-Linking Experts 2018 Meeting 2018 Zurich, organised by the Light for Sight Foundation,  took place in Zurich for the ... Read more

Cooling the cornea… for better cross-linking

EyeWorld’s Jonathan Kahn (JK) interviews Farhad Hafezi (FH) on a new method that might improve the efficacy of corneal cross-linking: ... Read more

PACK-CXL: Cross-linking the cornea… to conquer infection

EyeWorld’s Jonathan Kahn (JK) interviews Farhad Hafezi (FH) for a PACK-CXL update. Transcript JK: Good morning from the ESCRS conference ... Read more

ELZA at ESCRS 2018

The ELZA Institute's surgeons and researchers spent four days in Vienna at the 36th Congress of the ESCRS, and went ... Read more

Children: to cross-link or not to cross-link?

Children: to cross-link or not to cross-link? If a person is going to develop keratoconus, that person is more likely to ... Read more

Cross-Linking in thin corneas: simple, personal and more precise

Keratoconus is the progressive thinning of the cornea, and corneal cross-linking (CXL) can successfully treat it. The application of riboflavin ... Read more

Thyroid and Vision

Prof. Hafezi in a video interview with EyeWorld at the World Ophthalmology Congress 2018 in Barcelona about the relationship between ... Read more

CXL controversy 2018: Hype oder reality?

Prof. Hafezi in a controversy about Cross-Linking with Prof. Damien Gatinel at the Science2Clinix-Kongress in Bangalore.  ... Read more
Loading...
Menu

The ELZA Institute

EN
DE |